largescal
genom
sequenc
project
first
advanc
knowledg
theoret
composit
proteom
led
develop
dna
microarray
studi
gene
transcript
organismscal
use
genom
sequenc
data
guid
direct
examin
proteom
enabl
studi
hostpathogen
interact
occur
beyond
level
gene
transcript
soon
becam
evid
direct
correl
gene
express
protein
abund
rare
drive
develop
new
approach
studi
complex
proteom
protein
microarray
ideal
suit
serv
purpos
enorm
potenti
applic
biomark
discoveri
diagnosi
vaccin
develop
drug
discoveri
infecti
diseas
fluorescencebas
detect
protein
interact
similar
gene
array
method
data
analysi
often
employ
approach
previous
develop
genom
transcript
studi
number
protein
print
singl
microarray
surfac
also
approach
upper
limit
nucleicacid
base
system
multiplex
fluoresc
probe
limit
abil
separ
signal
overlap
emiss
spectra
gener
pairwis
comparison
differenti
label
experiment
control
sampl
analyz
exampl
serum
igg
igm
bind
array
protein
independ
probe
fluoresc
label
secondari
antibodi
detect
confoc
laser
scanner
genepix
molecular
devic
sunnyval
ca
usa
complet
highthroughput
screen
thousand
interact
perform
accur
rapidli
figur
direct
label
probe
may
also
use
though
structur
function
may
advers
affect
labelfre
techniqu
provid
realtim
measur
case
yield
kinet
figur
provid
insight
molecular
interact
surfac
plasmon
reson
spr
nanowir
surfac
mass
spectrometri
exampl
labelfre
method
appli
field
protein
microarray
limit
number
sprbase
instrument
current
avail
analysi
complex
protein
microarray
spr
imag
spri
recent
promis
develop
planar
array
use
slide
chip
immobil
captur
molecul
common
suspens
array
base
microbead
mani
import
applic
xmap
technolog
develop
luminex
corpor
austin
tx
usa
use
micromet
polym
bead
infus
two
fluoresc
dye
differ
ratio
yield
distinct
bead
set
bind
measur
perform
flow
cytometri
two
laser
one
identif
bead
sampl
beadbas
array
use
standard
assay
upper
limit
independ
immobil
probe
protein
microarray
increasingli
use
infecti
diseas
research
identifi
new
biomark
involv
diseas
process
target
immun
respons
contrast
proteom
techniqu
gel
electrophoresi
mass
spectrometri
array
probe
known
conform
easili
highthroughput
applic
requir
examin
entir
proteom
infecti
agent
varieti
format
develop
studi
pathogen
proteom
captur
reversephas
exampl
abundancebas
microarray
produc
spot
either
antibodi
antigen
substrat
array
probe
serum
plasma
biolog
sampl
detect
bind
interact
microarray
base
wellcharacter
antibodi
specif
use
identifi
biomark
quantif
protein
aptam
affibodi
engin
antibodi
fragment
altern
captur
molecul
antigen
array
find
applic
serodiagnosi
diseas
antibodyrespons
profil
evalu
immun
vaccin
reversephas
protein
microarray
rppm
small
amount
biolog
sampl
cell
tissu
sera
plasma
directli
print
slide
array
probe
singl
protein
interest
detect
label
antibodi
rppm
success
use
screen
cellsign
pathway
posttransl
modif
protein
biochem
activ
array
protein
also
analyz
enzym
activ
substrat
activ
protein
interact
protein
nucleic
acid
drug
host
antibodi
respons
provid
signatur
pathogen
protein
display
infecti
diseas
captur
detect
microarray
studi
vaccinia
viru
bacterium
yersinia
pesti
exemplifi
applic
antigen
microarray
analysi
immun
respons
figur
vaccinia
larg
dna
viru
orthopoxvirida
replic
cytoplasm
host
cell
genom
encod
protein
virion
compris
approxim
protein
phenotyp
variabl
occur
protein
encod
termin
region
genom
associ
host
virul
immun
evas
terminalregion
protein
secret
cell
infect
interfer
host
immun
bind
complement
factor
cytokin
chemokin
other
interfer
signal
pathway
regul
host
gene
express
apoptosi
construct
proteom
microarray
genom
dna
copenhagen
vaccin
strain
dryvax
use
templat
pcr
amplif
open
read
frame
orf
gateway
recombin
clone
invitrogen
carlsbad
ca
usa
employ
facilit
highthroughput
product
protein
orf
clone
dna
clone
sequenceverifi
entir
length
insert
baculovirusbas
express
use
produc
recombin
viral
protein
gsttag
fusion
ensur
high
yield
properli
fold
protein
posttransl
modif
similar
encount
human
host
gsttag
protein
cell
lysat
affin
purifi
homogen
singl
step
use
glutathioneagaros
plate
analyz
correct
size
abund
western
blot
viru
control
protein
print
onto
glass
slide
coat
thin
layer
nitrocellulos
ultim
proteom
success
express
purifi
array
standard
assay
measur
antibodi
interact
protein
vaccinia
proteom
microarray
first
develop
pool
therapeut
human
sera
collect
vacciniaimmun
individu
vig
data
compar
result
obtain
individu
vaccin
smallpox
use
dryvax
assay
consist
incub
dilut
serum
microarray
surfac
wash
final
detect
fluoresc
label
antiig
antibodi
fluoresc
imag
captur
scan
confoc
laser
genepix
molecular
devic
small
sampl
volum
requir
approach
ideal
limit
amount
sampl
consum
often
necessari
clinic
materi
high
level
reproduc
low
background
appar
repetit
assay
confirm
previous
report
antigen
identifi
new
protein
may
import
neutral
viral
infect
incub
microarray
vig
identifi
nine
protein
consist
bound
antibodi
antibodi
interact
protein
insignific
requir
treatment
suppress
nonspecif
signal
antigen
also
recogn
antibodi
individu
subject
follow
primari
smallpox
vaccin
divers
function
consist
regulatori
surfac
core
secret
protein
ident
vaccinia
protein
cluster
protein
recogn
primari
secondari
vaccin
subject
base
sole
signal
intens
vaccinia
protein
previous
report
antibodyrecogn
antigen
nine
antigen
protein
identifi
bind
antibodi
nonvaccin
sera
confirm
specif
antibodyantigen
interact
howev
reactiv
antibodi
vig
nonvaccin
control
sera
suggest
crossreact
nonspecif
interact
result
indic
small
subset
protein
present
within
complex
orthopoxviru
proteom
associ
antibodi
respons
addit
human
respons
individu
protein
variabl
sera
half
subject
contain
igg
recogn
vaccinia
protein
remain
sampl
recogn
one
three
protein
antibodi
individu
recogn
greater
number
viral
protein
boost
vaccin
compar
singl
vaccin
suggest
repeat
infect
expand
total
number
protein
recogn
igg
previou
report
similar
studi
vaccinia
analyz
serolog
respons
vaccinia
smallpox
observ
signific
amount
antibodi
respons
vaccinia
involv
viru
neutral
could
use
potenti
marker
diagnost
vaccin
develop
later
report
evalu
attenu
smallpox
modifi
vaccinia
viru
ankara
mva
altern
dryvax
vaccin
compar
antibodi
profil
sera
human
monkey
overal
immunogen
mva
report
compar
dryvax
vaccin
studi
conclud
mva
may
use
altern
dryvax
vaccinia
viru
microarray
expand
allow
analysi
addit
poxvirus
monkeypox
zoonot
viral
diseas
occur
primarili
central
west
africa
immun
monkeypox
provid
vaccin
smallpox
caus
close
relat
variola
viru
differenti
antibodi
respons
monkeypox
viru
infect
human
smallpox
vaccin
develop
protein
microarray
cover
protein
repres
proteom
monkeypox
viral
clade
central
west
africa
includ
coverag
protein
vaccinia
viru
proteom
refer
orthopox
vaccin
serum
igg
cynomolgu
macaqu
recov
monkeypox
recogn
least
separ
protein
within
orthopox
metaproteom
protein
recogn
igg
vaccin
human
antigen
detect
sera
human
vaccine
also
recogn
igg
convalesc
macaqu
greatest
level
igg
bind
macaqu
occur
structur
protein
membran
scaffold
protein
signific
igm
respons
direct
toward
monkeypox
viru
detect
onset
clinic
symptom
macaqu
result
studi
suggest
antibodi
vaccin
recogn
small
number
protein
share
pathogen
viral
strain
recoveri
infect
also
involv
humor
immun
antigen
uniqu
recogn
within
monkeypox
viru
proteom
unpublish
data
identifi
antibodi
biomark
could
distinguish
plagu
infect
caus
bacteri
pathogen
develop
microarray
compris
proteom
bacterium
yersinia
pesti
chromosom
pesti
encod
approxim
protein
addit
episom
express
comparison
proteom
pesti
kim
contain
individu
protein
common
close
relat
enter
pathogen
pseudotuberculosi
contain
approxim
protein
chromosom
plu
plasmid
microarray
compris
protein
repres
orf
present
within
pesti
genom
manner
similar
vaccinia
microarray
pesti
protein
produc
fulllength
polypeptid
fuse
gst
affin
isol
tag
vitro
translat
method
base
e
coli
lysat
use
express
protein
gramneg
background
orf
clone
fulli
sequenc
confirm
qualiti
ident
affinitypurifi
protein
character
sd
gel
western
blot
probe
antigst
antibodi
differ
approach
studi
antibodi
repertoir
plagu
rabbit
nonhuman
primat
investig
base
result
experi
use
pesti
proteom
microarray
identifi
new
candid
antibodi
biomark
bacteri
infect
pattern
crossreact
panel
gramneg
pathogen
abl
cluster
protein
recogn
antibodi
three
group
common
protein
gramneg
bacteria
combin
protein
uniqu
one
pathogen
protein
uniqu
one
pathogen
exampl
demonstr
power
highdens
proteom
microarray
dissect
complex
immunolog
relationship
among
group
relat
human
pathogen
convalesc
sera
vaccin
nonhuman
primat
surviv
otherwis
lethal
aerosol
challeng
pesti
plagu
bacillu
anthraci
ame
spore
anthrax
also
examin
addit
lcrv
protein
compris
vaccin
compon
subset
protein
pesti
proteom
recogn
antibodi
plagu
survivor
none
detect
antibodi
anthrax
survivor
nonchalleng
control
signatur
pattern
antibodi
recognit
identifi
reflect
ortholog
relationship
among
proteom
bacteria
high
degre
crossreact
antibodi
respons
burkholderia
relat
bacteria
also
previous
report
protein
microarray
consist
pesti
protein
use
li
et
al
profil
antibodi
respons
live
plagu
vaccin
rabbit
sentinel
anim
plagu
patient
predomin
respons
observ
protein
addit
v
antigen
rabbit
plagu
patient
identifi
protein
potenti
serodiagnost
biomark
candid
found
antibodi
respons
differ
plagu
foci
respons
differ
clinic
symptom
addit
microarray
studi
antibodi
respons
bacteri
pathogen
report
sundaresh
et
al
develop
protein
microarray
reactiv
francisella
tularensi
protein
deriv
larger
chip
studi
identifi
set
immunodomin
antigen
f
tularensi
patient
suitabl
diagnosi
develop
anoth
studi
similar
protein
microarray
approach
employ
find
immunodomin
antigen
mice
vaccin
kill
f
tularensi
vaccin
challeng
virul
f
tularensi
strain
studi
found
antigen
addit
known
immunodomin
antigen
f
tularensi
discov
method
also
first
publish
report
use
protein
microarray
studi
protect
immun
respons
infecti
agent
immunoreact
antigen
coxiella
burnetti
caus
agent
q
fever
identifi
use
protein
microarray
consist
c
burnetti
proteom
assembl
use
cell
free
protein
express
system
serum
q
fever
patient
individu
vaccin
qvax
vaccin
strongli
react
antigen
c
burnetti
confirm
elisa
includ
antigen
isol
e
coli
express
system
yet
anoth
studi
human
goat
antibodi
respons
brucella
melitensi
infect
analyz
find
differenti
recognit
antigen
two
host
speci
serodiagnost
protein
potenti
valu
diagnost
purpos
brucellosi
diagnos
measur
antibodi
lipopolysaccharid
lp
distinguish
past
present
infect
endem
area
antibodi
respons
lyme
borreliosi
diseas
human
mice
studi
barbour
et
al
use
protein
microarray
compris
protein
borrelia
burgdorferi
comprehens
analysi
sera
b
burgdorferi
patient
rodent
reveal
small
set
antigen
elicit
antibodi
respons
host
major
b
burgdorferi
protein
induc
antibodi
also
possibl
focu
specif
subset
antigen
identifi
bioinformat
exampl
protein
array
produc
outer
membran
protein
pseudomona
aeruginosa
construct
studi
immun
respons
patient
sever
antibodybind
antigen
identifi
group
potenti
diagnost
marker
anoth
exampl
recombin
niesseria
meningitidi
protein
array
use
screen
serum
mening
patient
immun
respons
phasevari
express
protein
develop
new
proteom
method
driven
part
need
identifi
new
type
infect
biomark
though
studi
antibodi
respons
domin
field
protein
microarray
consid
altern
approach
examin
catagori
hostpathogen
interact
research
area
wellestablish
cell
proteom
data
prime
target
exampl
mani
host
factor
associ
phagosom
identifi
protein
microarray
may
provid
conveni
model
system
examin
interact
pathogen
proteom
associ
portal
entri
similar
manner
target
microarray
compris
pathogen
protein
may
use
examin
host
interact
publish
exampl
develop
field
studi
mention
one
report
rppm
along
techniqu
use
examin
phosphoprotein
signal
pathway
primari
human
small
airway
epitheli
cell
infect
bacillu
anthraci
identifi
reduc
akt
protein
kinas
b
phosphoryl
contributor
increas
bacteri
surviv
pathogen
anoth
studi
protein
group
b
streptococci
array
chip
probe
human
fibronectin
fibrinogen
bind
protein
wellknown
target
gramposit
bacteria
use
purifi
wellcharacter
protein
assembl
microarray
insur
highest
qualiti
reproduc
result
howev
high
level
qualiti
control
requir
sequenc
purifi
character
element
proteom
microarray
exampl
describ
may
import
provision
screen
purpos
coupl
transcriptiontransl
reaction
previous
report
rapid
method
develop
protein
microarray
number
infecti
organ
bypass
sequenc
purif
step
techniqu
transcript
translat
occur
simultan
synthes
protein
parallel
pcr
product
directli
chip
presum
result
obtain
method
requir
followup
studi
rigor
control
confirm
protein
situ
array
pisa
develop
taussig
first
produc
dna
construct
pcr
protein
interest
promot
translat
initi
follow
immobil
use
n
c
termin
tag
sequenc
anoth
approach
call
nucleic
acid
programm
protein
array
nappa
includ
slide
coat
avidin
captur
biotinyl
plasmid
dna
synthes
protein
protein
fuse
tag
synthes
immobil
chip
coat
molecul
bind
tag
et
al
describ
techniqu
call
dna
array
protein
array
dapa
util
singl
dna
array
make
multipl
copi
protein
array
one
exampl
selfassembl
nappabas
cellfre
express
system
use
construct
protein
microarray
protein
produc
varicella
zoster
viru
vzv
caus
chickenpox
three
set
antigen
vzv
proteom
identifi
human
sera
may
use
defin
clinic
statu
infect
diagnost
anoth
vzv
protein
array
produc
e
coli
express
system
later
use
detect
antibodi
human
sera
reactiv
vzv
viral
protein
ge
antigen
identifi
studi
show
highconfid
determin
serolog
respons
vzv
although
altern
situ
synthesi
method
rapid
without
signific
shortcom
difficult
character
protein
express
chip
contrast
direct
spot
purifi
protein
two
studi
investig
antibodi
respons
vzv
protein
array
made
either
nappa
cellfre
express
system
e
coli
express
system
antibodi
sera
patient
recogn
three
microarray
vzv
protein
produc
recombinantli
e
coli
wherea
ident
protein
recogn
nappa
protein
expressionbas
protein
microarray
interestingli
protein
abundantli
express
nappa
protein
microarray
suggest
fold
correctli
expos
linear
epitop
bind
despit
limit
microarray
base
situ
synthesi
offer
simplic
effici
highthroughput
capabl
rel
small
proteom
virus
increas
divers
consid
variat
clinic
isol
exampl
human
papilloma
viru
produc
protein
sequenc
may
diverg
strain
viru
protein
microarray
develop
human
papilloma
viru
type
use
examin
patient
sera
compar
asymptomat
subject
studi
identifi
protein
reactiv
antigen
patient
group
howev
protein
use
diagnost
biomark
differ
patient
asymptomat
subject
signific
anoth
report
bead
suspens
multiplex
array
luminex
xmap
use
studi
serolog
respons
antigen
human
papilloma
viru
data
correl
well
elisa
result
addit
bead
array
abl
measur
weak
antibodi
respons
protein
array
construct
six
coronavirus
includ
sever
acut
respiratori
syndrom
sar
use
screen
serum
sampl
virusspecif
antibodi
microarray
data
predict
sar
infect
patient
correctli
specif
high
effici
low
cost
highthroughput
natur
chemic
synthes
peptid
signific
advantag
compar
product
recombin
polypeptid
therefor
peptid
microarray
explor
anoth
altern
recombin
protein
limit
degre
success
chemic
synthes
peptid
microarray
repres
major
antigen
hepat
b
c
virus
human
immunodefici
viru
epsteinbarr
viru
syphili
construct
glass
slide
antibodi
respons
simultan
detect
assay
show
high
sensit
specif
diagnost
identif
virus
anoth
proof
principl
studi
report
identifi
diagnost
relev
peptid
use
peptid
array
deduc
bioinformat
data
echinococcu
granulosa
tapeworm
infect
achiev
sensit
specif
compar
elisa
altern
fulllength
polypeptid
express
purif
protein
domain
may
improv
yield
stabl
product
use
microarray
one
report
studi
total
protein
domain
pdz
etc
immobil
nitrocellulos
screen
peptid
result
prove
immobil
domain
stabl
could
use
bind
studi
kaushanski
et
al
construct
array
base
protein
interact
domain
src
homolog
phosphotyrosin
bind
domain
mous
pdz
domain
produc
recombin
e
coli
array
requir
low
sampl
consumpt
may
reduc
fals
posit
rate
advanc
knowledg
specif
recognit
event
requir
substitut
peptid
singl
protein
domain
fulllength
protein
ensur
import
epitop
miss
purpos
studi
antibodi
interact
protein
stabil
import
particularli
challeng
factor
use
protein
microarray
highthroughput
natur
construct
tend
sacrific
detail
knowledg
individu
protein
method
avail
assess
fold
function
array
protein
immedi
use
recombin
protein
construct
fusion
tag
facilit
fold
translat
offer
partial
solut
especi
proper
fold
fusion
protein
readili
assess
exampl
unfold
glutathionestransferas
gst
bind
glutathion
tripeptid
ligand
gst
henc
purif
scheme
employ
gst
fusion
favor
protein
stabl
structur
fusion
tag
also
provid
conveni
marker
monitor
qualiti
control
protein
spot
figur
howev
fusion
tag
may
hinder
protein
access
alter
function
way
protein
may
denatur
print
storag
enzym
denaturingsensit
protein
assess
print
includ
microarray
antibodi
natur
choic
use
captur
molecul
due
specif
affin
eas
product
potenti
engin
probe
develop
analysi
antibodi
specif
crossreact
simplifi
screen
target
offtarget
protein
print
microarray
antibodi
array
routin
use
field
biomark
discoveri
valid
detect
bind
molecul
antibodi
array
usual
done
direct
label
protein
sampl
serum
cell
tissu
sandwich
format
similar
elisa
exampl
protein
abund
cell
determin
haab
et
al
use
antigen
antibodi
reaction
first
publish
report
use
twocolor
differenti
label
sampl
protein
microarray
microarray
format
also
conveni
standard
routin
analysi
analyt
present
screen
assay
cytokin
releas
cell
cultur
antibodybas
microarray
multiplex
detect
cholera
diphtheria
staphylococc
enterotoxin
b
tetanu
toxin
anthrax
protect
antigen
lethal
factor
report
competit
assay
label
unlabel
toxin
serum
use
simultan
detect
toxin
antibodi
microarray
anoth
report
sandwich
fluoresc
immunoassay
base
antibodi
microarray
format
develop
captur
detect
e
coli
later
screen
larg
number
food
sampl
highthroughput
manner
simultan
detect
e
coli
salmonella
typhimurium
major
drawback
captur
microarray
welldefin
highqual
antibodi
microorgan
avail
engin
antibodi
fragment
potenti
altern
approach
acceler
develop
antigencaptur
molecul
antibodi
fragment
fab
portion
igg
phage
display
librari
recombin
singl
chain
variabl
fragment
scfv
contain
antigenbind
motif
use
place
antibodi
protein
microarray
develop
decreas
crossreact
also
observ
fragment
compar
fulllength
antibodi
thinlay
nitrocellulos
chemic
modifi
surfac
glass
silicon
gold
polym
gener
use
immobil
microarray
protein
buffer
addit
like
glycerol
polyethylen
glycol
sugar
prevent
dri
protein
choic
buffer
care
select
match
type
surfac
use
array
altern
gelbas
surfac
made
polyacrylamid
agaros
provid
hydrophil
environ
regardless
print
substrat
select
microarray
protein
must
retain
function
stabil
prepar
use
though
may
possibl
directli
examin
element
array
import
includ
print
control
interact
protein
test
function
use
sever
method
protein
spot
onto
substrat
choic
technolog
use
impact
spot
consist
speed
spot
diamet
eas
use
turn
final
spot
qualiti
requir
print
protein
depend
method
detect
control
laboratori
environ
maintain
constant
temperatur
humid
cleanroom
condit
vastli
improv
print
consist
print
solid
pin
exampl
stealth
pin
arrayit
corport
sunnyval
ca
usa
reli
capillari
forc
releas
spot
contact
surfac
result
diamet
spot
depend
buffer
composit
pin
diamet
dippen
lithographi
dpn
use
atom
forc
microscopi
microcantilev
deposit
spot
rang
diamet
nano
enabl
bioforc
nanosci
ame
ia
usa
inkjet
printer
exampl
arrayjet
roslin
scotland
use
piezoelectr
element
transfer
protein
solut
form
droplet
target
surfac
result
spot
diamet
pin
inkjet
spot
method
deposit
small
amount
protein
requir
highli
concentr
sampl
unfortun
highli
concentr
sampl
may
fail
adsorb
complet
surfac
tend
spread
hydrat
new
continu
flow
microspot
method
wasatch
microfluid
taylorsvil
ut
usa
use
microfluid
channel
network
continu
circul
protein
sampl
spot
achiev
uniform
maximum
protein
adsorpt
techniqu
may
especi
use
dilut
crude
protein
sampl
array
fluorescencebas
label
probe
commonli
use
detect
bind
event
due
primarili
simplic
sensit
exampl
aminereact
dye
cyanin
label
probe
biotin
follow
detect
avidinfluoresc
dye
conjug
ccd
camera
fluoresc
slide
scanner
use
detect
label
probe
within
defin
grid
area
sandwich
immunoassay
method
provid
increas
sensit
time
reduc
nonspecif
bind
use
limit
avail
pair
antibodi
use
roll
circl
amplif
rca
method
dramat
increas
fluoresc
signal
intens
thu
increas
sensit
protein
microarray
detect
method
scheme
protein
label
biotin
recogn
antibodi
conjug
primer
circular
dna
hybrid
fluoresc
label
oligonucleotid
use
elong
dna
detect
univers
rca
signal
amplif
scheme
use
measur
cytokin
multiplex
format
total
cytokin
simultan
measur
antibodi
microarray
demonstr
even
larger
number
analyt
measur
technolog
thu
rca
power
tool
improv
detect
limit
protein
microarray
signal
amplif
current
fluorescencebas
detect
protein
microarray
limit
two
three
independ
probe
broad
emiss
profil
exhibit
dye
use
detect
often
overlap
background
fluoresc
emit
substrat
commonli
use
nitrocellulos
also
multipl
excit
emiss
channel
requir
detect
combin
fluoresc
marker
quantum
dot
qd
nanoparticl
one
altern
fluoresc
dye
qd
semiconduct
fluorophor
extrem
bright
resist
photobleach
multiplex
capabl
contain
inorgan
fluoresc
core
commonli
cdse
coat
shell
anoth
semiconductor
cd
zn
import
properti
qd
refer
protein
microarray
detect
absorb
light
broad
wavelength
uv
visibl
rang
emit
light
narrow
bandwidth
contrast
fluoresc
dye
addit
qd
surfac
may
modifi
suitabl
chemistri
immobil
biomolecul
streptavidinco
qd
protein
microarray
format
use
detect
six
differ
cytokin
picomolar
concentr
current
practic
limit
multiplex
qd
addit
multiplex
strategi
previous
describ
detail
beadbas
microarray
offer
one
solut
multiplex
commerci
avail
method
develop
luminex
xmap
platform
xmap
technolog
base
polym
bead
incorpor
fluoresc
dye
produc
uniqu
signatur
bead
conjug
differ
molecul
perform
multiplex
assay
discret
interact
monitor
simultan
use
technolog
perhap
extend
bead
set
near
futur
antigen
peptid
attach
luminex
bead
antibodi
respons
papillomaviru
epsteinbarr
viru
mycobacterium
tuberculosi
report
becton
dickinson
franklin
lake
nj
usa
market
cytometr
bead
array
cba
system
anoth
multiplex
beadbas
assay
includ
flow
cytometri
cytokin
chemokin
mous
isotyp
signal
molecul
analysi
labelfre
detect
method
use
realtim
monitor
bind
event
minim
artifact
caus
use
label
probe
spr
imag
technolog
wide
use
microarray
format
mani
applic
spr
labelfre
allow
realtim
monitor
addit
abil
measur
kinet
molecular
interact
figur
spr
imag
develop
simultan
measur
spr
dip
chang
array
format
record
ccd
camera
gratingcoupl
flexchip
gebiacor
piscataway
nj
usa
prismcoupl
spriplex
horiba
scientif
edison
nj
usa
proteon
biorad
hercul
ca
usa
spri
system
exampl
commerci
avail
spri
microarray
system
model
proteinprotein
interact
system
report
consist
protein
human
papillomaviru
complex
protein
use
spri
system
anoth
exampl
arraybas
spectral
spr
system
use
measur
antibodi
respons
mump
viru
infect
system
reflect
light
array
collect
fiber
optic
spectromet
analysi
laboratori
routin
use
spri
microarray
valid
interact
detect
primari
microarray
screen
fluoresc
probe
readout
spot
size
must
larg
enough
resolut
commonli
use
ccd
imag
practic
array
densiti
current
less
independ
immobil
probe
addit
labelfre
detect
method
describ
surfaceenhanc
laser
desorptionion
time
flight
mass
spectrometri
selditofm
use
low
throughput
method
onchip
purif
protein
ioniz
detect
howev
approach
success
identifi
biomark
parasit
diseas
marker
found
studi
intact
host
protein
matrixassist
laser
desorptionion
maldi
ms
combin
gel
surfac
silicon
nanopor
nanovi
also
use
biomark
discoveri
msbase
detect
system
import
specif
applic
limit
advanc
develop
microarray
format
current
limit
use
primari
screen
tool
nanowirebas
system
detect
chang
conduct
result
molecular
bind
possibl
make
array
nanowir
nanowir
coat
specif
captur
molecul
ganteliu
et
al
report
magnet
beadbas
multiplex
format
detect
autoantibodi
antigen
compar
assay
result
fluorescencebas
detect
system
although
magnet
beadbas
system
rapid
suffici
sensit
routin
use
despit
rapid
progress
protein
microarray
develop
standard
method
data
handl
analysi
univers
accept
fluoresc
scanner
made
differ
commerci
vendor
use
standalon
softwar
analyz
data
assay
protocol
use
investig
may
vari
wide
henc
often
difficult
compar
studi
report
differ
group
need
formul
standard
method
protein
microarray
data
handl
analysi
number
report
outlin
way
normal
protein
microarray
data
mainli
differ
approach
antibodi
microarray
normal
method
includ
concentrationdepend
analysi
spike
intern
standard
algorithmbas
signific
pro
con
invitrogenlif
technolog
carlsbad
ca
usa
develop
data
analysi
packag
protoarray
prospector
specif
design
protein
antigen
microarray
includ
suit
statist
method
bioarray
softwar
environ
base
softwar
packag
microarray
data
manag
analysi
http
basetheplus
develop
lund
univers
sweden
also
address
issu
outlin
howev
remain
seen
rapidli
standard
adopt
research
commun
antibodi
primari
biomark
infect
commonli
use
diagnosi
measur
vaccin
efficaci
discoveri
diseas
intervent
protein
microarray
import
tool
measur
complex
antigenantibodi
interact
hostpathogen
interact
differ
stage
diseas
major
impedi
develop
protein
microarray
inher
complex
protein
avail
wellcharacter
antibodi
infecti
agent
standard
statist
method
analysi
data
howev
expect
mani
issu
resolv
come
year
tool
use
frequent
infecti
diseas
research
